Ten Reaxys® PhD Prize Candidates Selected to Present at Symposium in London

PhD Prize winners will be announced on September 23

New York, NY, August 4, 2016

Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced that 10 Reaxys PhD Prize candidates have been short-listed from the 45 chemists nominated in May. The candidates will present at the annual Reaxys Prize Symposium to be held in conjunction with the New Scientist Live festival in London from September 22-23.

The oral presentation in September will be the last step in the reviewing process of the Reaxys PhD Prize, an international award that recognizes and rewards the most innovative research produced by chemistry’s rising stars. The jury, which consists of members of the Reaxys Advisory Board, will chose three winners, who will be announced at the Symposium dinner on September 23.

The 10 shortlisted candidates are:

  • Nickolas Anderson from the Bart group, Purdue University - West Lafayette
  • Chuyang Cheng from the Stoddart group, Northwestern University
  • Lauren Doyle from the Piers group, University of Calgary
  • Pascal Ellerbrock from the Trauner group, Ludwig-Maximilian University of Munich
  • Sebastian Grundner from the Lercher group, Technical University of Munich
  • Jamie Hicks from the Jones group, Monash University
  • Jiheong Kang from the Aida group, University of Tokyo
  • Jarad Mason from the Long group, University of California Berkeley
  • Yusuke Masuda from the Murakami group, Kyoto University
  • Alison Wendlandt from the Stahl group, University of Wisconsin - Madison

All of the original 45 finalists from this year’s prize have been invited to attend the Symposium and present their work during a poster session. The jury’s review criteria include the originality, innovation, applicability, importance, and rigor of the reported research.

Since its introduction in 2010, the Reaxys PhD Prize has received more than 3,000 submissions, from nearly 650 universities worldwide. The Prize aims to not only nurture advances in chemistry by giving talented young chemists who have produced groundbreaking research the recognition they deserve, but also present them with opportunities to extend their network, unlock new sources of inspiration and share knowledge.

Read more about the Reaxys PhD Prize, this year’s 10 short-listed candidates and the Symposium.

---

About Reaxys
Reaxys empowers chemistry research and development by providing structure, property and reaction data, experimental procedures and literature. It is designed to support early drug discovery, education, material selection and synthesis planning; its capabilities include data export and integration to enable harmonized analysis of in-house and external data. Reaxys improves R&D productivity by delivering the facts the way chemists need them. www.elsevier.com/reaxys

Reaxys is a trademark of RELX Intellectual Properties SA, used under license.

About Elsevier
Elsevier is a global information analytics company that helps institutions and professionals progress science, advance healthcare and improve performance for the benefit of humanity. Elsevier provides digital solutions and tools in the areas of strategic research management, R&D performance, clinical decision support, and professional education; including ScienceDirect, Scopus, ClinicalKey and Sherpath. Elsevier publishes over 2,500 digitized journals, including The Lancet and Cell, more than 35,000 e-book titles and many iconic reference works, including Gray's Anatomy. Elsevier is part of RELX Group, a world-leading provider of information and analytics to professionals and business customers, in a wide range of industries. www.elsevier.com

Media contact
Christopher Capot
Director, Corporate Relations, Elsevier
+1 917 704 5174
c.capot@elsevier.com